IMPORTANT: This is a new action! Even if you’ve already contacted your congressional representatives about establishing the patient registry, please also take this action targeted at Congresswoman Nita Lowey (D-NY 17th District) and Congresswoman Rosa DeLauro (D-CT 3rd District).
FDA Approves KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Patients with Unresectable or Metastatic Malignant Pleural Mesothelioma
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
